Ginkgo Bioworks Holdings annual current ratio
2020
2021
2022
2023
2024
2025
Ginkgo Bioworks Holdings Current Ratio Growth & History (DNA)
Ginkgo Bioworks Holdings's current ratio was 4.92 for fiscal 2025.
View full Ginkgo Bioworks Holdings company overviewGinkgo Bioworks Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.92 | −0.70 | −12.50% |
| 2024 | 2024-12-31 | 5.62 | −0.49 | −8.09% |
| 2023 | 2023-12-31 | 6.11 | −2.27 | −27.08% |
| 2022 | 2022-12-31 | 8.38 | −4.40 | −34.43% |
| 2021 | 2021-12-31 | 12.79 | 6.96 | +119.49% |
| 2020 | 2020-12-31 | 5.83 | — | — |
Ginkgo Bioworks Holdings quarterly current ratio
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 4.57 | −0.84 | −15.46% |
| Q1 2026 | 2026-03-31 | 5.15 | 0.27 | +5.53% |
| Q4 2025 | 2025-12-31 | 4.92 | −0.70 | −12.50% |
| Q3 2025 | 2025-09-30 | 4.39 | −1.40 | −24.17% |
| Q2 2025 | 2025-06-30 | 5.41 | 0.69 | +14.70% |
| Q1 2025 | 2025-03-31 | 4.88 | −0.46 | −8.63% |
| Q4 2024 | 2024-12-31 | 5.62 | −0.49 | −8.09% |
| Q3 2024 | 2024-09-30 | 5.79 | −0.99 | −14.58% |
| Q2 2024 | 2024-06-30 | 4.71 | −2.78 | −37.06% |
| Q1 2024 | 2024-03-31 | 5.34 | −1.58 | −22.85% |
| Q4 2023 | 2023-12-31 | 6.11 | −2.27 | −27.08% |
| Q3 2023 | 2023-09-30 | 6.78 | −4.94 | −42.13% |
| Q2 2023 | 2023-06-30 | 7.49 | −4.35 | −36.74% |
| Q1 2023 | 2023-03-31 | 6.92 | −3.79 | −35.36% |
| Q4 2022 | 2022-12-31 | 8.38 | −4.40 | −34.43% |
| Q3 2022 | 2022-09-30 | 11.71 | −8.34 | −41.58% |
| Q2 2022 | 2022-06-30 | 11.84 | — | — |
| Q1 2022 | 2022-03-31 | 10.71 | — | — |
| Q4 2021 | 2021-12-31 | 12.79 | 6.96 | +119.49% |
| Q3 2021 | 2021-09-30 | 20.05 | — | — |
| Q4 2020 | 2020-12-31 | 5.83 | — | — |
Ginkgo Bioworks Holdings current ratio trends
Over the last five fiscal years, Ginkgo Bioworks Holdings's current ratio decreased from 5.83 to 4.92, a change of −0.91. The latest reported quarter, Q2 2026, shows 4.57.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ginkgo Bioworks Holdings source filings ↗Community posts
Ginkgo joins a federally backed RNA-manufacturing project worth up to $17.5 million
Ginkgo Bioworks ($DNA) received a subcontract worth up to $17.5 million to participate in an ARPA-H program focused on RNA manufacturing. Waterfall Scientific is the prime contractor. The project, called ESCALATOR, is intended to combine co ...